GSK partners with CRISPR pioneer Doudna to search for new drugs

GSK partners with CRISPR pioneer Doudna to search for new drugs

Source: 
Stat
snippet: 

The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for new medicines, establishing a new lab in San Francisco and spending up to $67 million over five years.